Cargando…
Translation of genomics and epigenomics in prostate cancer: progress and promising directions
During the last several years, exciting discoveries have been made in prostate cancer (PCa) as a result of significant advances in genomic technology and information. For example, using genome-wide association studies, more than 100 inherited genetic variants associated with PCa risk have been ident...
Autores principales: | Liu, Wennuan, Xu, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955169/ https://www.ncbi.nlm.nih.gov/pubmed/27270344 http://dx.doi.org/10.4103/1008-682X.182820 |
Ejemplares similares
-
DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer
por: Liu, Wennuan
Publicado: (2016) -
Genomics and epigenomics
por: Garagnani, Paolo, et al.
Publicado: (2015) -
Prostate cancer: molecular and cellular mechanisms and their implications in therapy resistance and disease progression
por: Feng, Ninghan, et al.
Publicado: (2019) -
The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014) -
Translational progress on tumor biomarkers
por: Guo, Hongwei, et al.
Publicado: (2015)